The critical role of APOC3 in lipid metabolism, together with the dyslipidemia caused by APOC3 mutations [38, 39] and apolipoprotein C3 deficiency [33, 36], suggests an association of APOC3 SNPs and dyslipidemia-based NAFLD. This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.